Research Presented by The US Oncology Network Demonstrates How Community Practices Are Expanding Patient Access Through APP‑Led Models at ASCO 2026
Research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting by The US Oncology Network (The Network), an organization dedicated to advancing cancer care in the community and supported by McKesson, found that new patient consult models in benign hematology led by advanced practice providers (APP) can accelerate access to care and increase capacity across diverse community oncology settings.
McKesson’s Practice Insights Selected as a 2025 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
For the ninth consecutive year, the Centers for Medicare & Medicaid Services (CMS) has named McKesson a Qualified Clinical Data Registry (QCDR) approved to participate in the Merit-based Incentive Payment System (MIPS). As a CMS-designated QCDR, McKesson can collect and report clinical data on behalf of clinicians utilizing iKnowMed℠ electronic health record and integrated module, Practice Insights℠, a performance analytics tool powered by Ontada®, McKesson’s technology and insights business. The designation enables healthcare practices and providers utilizing iKnowMed to efficiently submit data directly for both MIPS and custom QCDR quality measures to CMS, eliminating the need to engage a separate registry vendor, streamlining data submission and minimizing administrative burden.
McKesson Designated by CMS as 2022 Qualified Clinical Data Registry
For the sixth consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) as a Qualified Clinical Data Registry (QCDR). The designation enables iKnowMed℠ electronic health record (EHR) users to efficiently submit data directly to CMS without engaging a separate registry vendor, streamlining data submission and minimizing administrative burden.
